168 related articles for article (PubMed ID: 26130719)
21. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
[TBL] [Abstract][Full Text] [Related]
22. [Functional study on TGF-beta/Smads signaling pathway in human ovarian cancer cells].
Zhang YY; Li X; Sui LH; Wang Q; Li P; Fu SB
Yi Chuan Xue Bao; 2004 Aug; 31(8):759-65. PubMed ID: 15481528
[TBL] [Abstract][Full Text] [Related]
23. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
[TBL] [Abstract][Full Text] [Related]
24. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
[TBL] [Abstract][Full Text] [Related]
26. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
27. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer.
Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY
J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038
[TBL] [Abstract][Full Text] [Related]
28. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
[TBL] [Abstract][Full Text] [Related]
29. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma.
Gao SB; Zheng QF; Xu B; Pan CB; Li KL; Zhao Y; Zheng QL; Lin X; Xue LX; Jin GH
Mol Cancer Res; 2014 Oct; 12(10):1388-97. PubMed ID: 24916103
[TBL] [Abstract][Full Text] [Related]
30. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.
Hellwinkel OJ; Asong LE; Rogmann JP; Sültmann H; Wagner C; Schlomm T; Eichelberg C
Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):38-45. PubMed ID: 21102547
[TBL] [Abstract][Full Text] [Related]
31. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
32. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
[TBL] [Abstract][Full Text] [Related]
33. TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.
Bai X; Jing L; Li Y; Li Y; Luo S; Wang S; Zhou J; Liu Z; Diao A
Cell Signal; 2014 Sep; 26(9):2030-9. PubMed ID: 24933703
[TBL] [Abstract][Full Text] [Related]
34. Effects of 4-nonylphenol and bisphenol A on stimulation of cell growth via disruption of the transforming growth factor-β signaling pathway in ovarian cancer models.
Park MA; Choi KC
Chem Res Toxicol; 2014 Jan; 27(1):119-28. PubMed ID: 24308608
[TBL] [Abstract][Full Text] [Related]
35. Phospho-Smad1 modulation by nedd4 E3 ligase in BMP/TGF-β signaling.
Kim BG; Lee JH; Yasuda J; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Jul; 26(7):1411-24. PubMed ID: 21308777
[TBL] [Abstract][Full Text] [Related]
36. The binding activity of Mel-18 at the Il17a promoter is regulated by the integrated signals of the TCR and polarizing cytokines.
Hod-Dvorai R; Jacob E; Boyko Y; Avni O
Eur J Immunol; 2011 Aug; 41(8):2424-35. PubMed ID: 21674483
[TBL] [Abstract][Full Text] [Related]
37. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
[TBL] [Abstract][Full Text] [Related]
38. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
39. TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells.
Dunfield LD; Dwyer EJ; Nachtigal MW
Endocrinology; 2002 Apr; 143(4):1174-81. PubMed ID: 11897669
[TBL] [Abstract][Full Text] [Related]
40. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
